1. Home
  2. ULS vs NBIX Comparison

ULS vs NBIX Comparison

Compare ULS & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ULS
  • NBIX
  • Stock Information
  • Founded
  • ULS 1894
  • NBIX 1992
  • Country
  • ULS United States
  • NBIX United States
  • Employees
  • ULS N/A
  • NBIX N/A
  • Industry
  • ULS
  • NBIX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ULS
  • NBIX Health Care
  • Exchange
  • ULS Nasdaq
  • NBIX Nasdaq
  • Market Cap
  • ULS 14.5B
  • NBIX 12.2B
  • IPO Year
  • ULS 2024
  • NBIX 1996
  • Fundamental
  • Price
  • ULS $72.55
  • NBIX $126.59
  • Analyst Decision
  • ULS Buy
  • NBIX Strong Buy
  • Analyst Count
  • ULS 7
  • NBIX 20
  • Target Price
  • ULS $69.43
  • NBIX $163.20
  • AVG Volume (30 Days)
  • ULS 647.6K
  • NBIX 857.9K
  • Earning Date
  • ULS 07-30-2025
  • NBIX 07-31-2025
  • Dividend Yield
  • ULS 0.72%
  • NBIX N/A
  • EPS Growth
  • ULS 28.34
  • NBIX N/A
  • EPS
  • ULS 1.67
  • NBIX 2.96
  • Revenue
  • ULS $2,905,000,000.00
  • NBIX $2,412,600,000.00
  • Revenue This Year
  • ULS $6.76
  • NBIX $16.29
  • Revenue Next Year
  • ULS $6.04
  • NBIX $15.08
  • P/E Ratio
  • ULS $43.50
  • NBIX $42.60
  • Revenue Growth
  • ULS 6.84
  • NBIX 21.73
  • 52 Week Low
  • ULS $40.99
  • NBIX $84.23
  • 52 Week High
  • ULS $73.98
  • NBIX $157.98
  • Technical
  • Relative Strength Index (RSI)
  • ULS N/A
  • NBIX 60.49
  • Support Level
  • ULS N/A
  • NBIX $123.04
  • Resistance Level
  • ULS N/A
  • NBIX $128.38
  • Average True Range (ATR)
  • ULS 0.00
  • NBIX 2.79
  • MACD
  • ULS 0.00
  • NBIX -0.26
  • Stochastic Oscillator
  • ULS 0.00
  • NBIX 67.50

About ULS UL Solutions Inc.

UL Solutions is a global leader specializing in a broad range of product testing, inspection, and certification services. UL Solutions is the for-profit branch out of three organizations under the UL Enterprise. TIC operations make up nearly all of UL Solutions' total revenue and are composed of two segments: industrial and consumer. UL Solutions' remaining business includes software and advisory, which complements its core TIC offerings. The firm operates globally.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.

Share on Social Networks: